Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring and Management of Hemolytic Disease of the Fetus and Newborn Based on an International Expert Delphi Consensus.
Mustafa HJ, Sambatur EV, Shamshirsaz AA, Johnson S, Moise KJ Jr, Baschat AA, Verweij EJTJ, Javinani A, Kilby MD, Lopriore E, Rose R, Devlieger R, Snowise S, Sachs UJ, Khalil A; HDFN Delphi Working Group. Mustafa HJ, et al. Among authors: sachs uj. Am J Obstet Gynecol. 2024 Nov 13:S0002-9378(24)01130-X. doi: 10.1016/j.ajog.2024.11.003. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 39547350
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study.
Burgmann CH, Sachs UJ, Trautmann-Grill K, Pfrepper C, Knöbl P, Greil R, Oldenburg J, Miesbach W, Holstein K, Eichler H, Möhnle P, Höpting M, Dobbelstein C, Klamroth R, Tiede A. Burgmann CH, et al. Among authors: sachs uj. Res Pract Thromb Haemost. 2024 Sep 5;8(7):102565. doi: 10.1016/j.rpth.2024.102565. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39420971 Free PMC article.
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. Among authors: sachs uj. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A. Hart C, et al. Among authors: sachs uj. J Thromb Haemost. 2024 Oct;22(10):2692-2701. doi: 10.1016/j.jtha.2024.06.010. Epub 2024 Jun 25. J Thromb Haemost. 2024. PMID: 38936699 Free article.
DNA Reference Reagents for Genotyping RH Variants.
Sippert E, Volkova E, Rippee-Brooks M, Denomme GA, Flegel WA, Lee C, Araojo R, Illoh O, Liu Z, Rios M; Collaborative Study Group. Sippert E, et al. J Mol Diagn. 2024 Jun;26(6):456-466. doi: 10.1016/j.jmoldx.2024.02.005. Epub 2024 Mar 16. J Mol Diagn. 2024. PMID: 38494079
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP.
Gil Gonzalez L, Won KD, Tawhidi Z, Cummins E, Cruz-Leal Y, Tundidor Cabado Y, Sachs UJ, Norris PAA, Shan Y, Bhakta V, Li J, Samudio I, Silva-Moreno B, Cerna-Portillo L, Pavon Oro A, Bergqvist P, Chan P, Moorehead A, Sholzberg M, Sheffield WP, Lazarus AH. Gil Gonzalez L, et al. Among authors: sachs uj. Blood Adv. 2024 Apr 23;8(8):1869-1879. doi: 10.1182/bloodadvances.2023012155. Blood Adv. 2024. PMID: 38330193 Free PMC article.
145 results